Real-time enrollment status for this castration-sensitive prostate carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:09 PM UTC
| NCT Number | NCT04734730 |
| Recruiting Status | Recruiting |
| Condition | Castration-Sensitive Prostate Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | January 28, 2026 (Jan 28, 2026) |
As of July 13, 2026: Clinical trial NCT04734730 is currently recruiting participants. This clinical trial study for castration-sensitive prostate carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04734730 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04734730 was last updated Jan 28, 2026 (January 28, 2026). HelloStudys verifies this status automatically.